|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.12.25 - 14:06
|
Das Comeback der Dividendenaktien (MarktEinblicke)
|
|
|
Vom Tech Glanz zum Cashflow: Warum Dividendenwerte nach 2025 wieder interessant werden und sich Umschichtungen lohnen könnten.
The post Das Comeback der Dividendenaktien first appeared on marktEINBLICKE....
|
|
|
|
|
|
|
03.12.25 - 14:06
|
Lipper-Untersuchung: Markt für aktive ETFs wächst viermal schneller als der Rest (Das Investment)
|
|
|
Die ETF-Branche erlebt einen stillen Wandel: Aktiv gemanagte börsengehandelte Fonds ziehen überproportional viel Kapital an.Aktiv gemanagte ETFs haben in Europa Ende Oktober 2025 ein Vermögen von 100,7 Milliarden Euro erreicht. Das entspricht einem Anteil von 3,98 Prozent am Gesamtvermögen der europäischen ETF-Branche. Passive ETFs verwalteten zum gleichen Zeitpunkt 2.429,3 Milliarden Euro, was einem Marktanteil von 96,02 Prozent entspricht. Die Zahlen stammen aus einer aktuellen Analyse von LSEG Lipper, einem Anbieter von Fondsdaten und -analysen. Vermögenszuwachs von knapp 50 Prozent...
|
|
|
|
|
03.12.25 - 14:06
|
Unacast Secures $28M Financing from Vector Capital to Accelerate Next Phase of Growth (Business Wire)
|
|
|
ASHBURN, Va.--(BUSINESS WIRE)--Unacast, the leading provider of global location intelligence, today announced it has secured $28 million in new financing from Vector Capital Management, L.P.'s (“Vector”), direct credit strategy, Vector Velocity.
The financing follows the late-2023 merger of Unacast and Gravy Analytics, which created one of the world's most comprehensive location intelligence platforms. Since then, Unacast has delivered strong double-digit growth, reached EBITDA-positive operations, and integrated both companies' technologies into a single, scaled platform that public- and private-sector organizations rely on for accurate insight into population movement and community trends.
The new capital will accelerate Unacast's product roadmap, enhance the quality and transparency of its global location intelligence solutions, and expand its go-to-market efforts. It will also support strategic M&A to strengthen the company's technology stack, broaden its data assets, and extend its reach acr...
|
|
|
03.12.25 - 14:06
|
Torginol Announces Acquisition of Chips Unlimited (Business Wire)
|
|
|
Transaction will expand Torginol's footprint and suite of products
SHEBOYGAN, Wis.--(BUSINESS WIRE)--Torginol, a leading manufacturer and marketer of decorative flake, quartz and other specialty products used in resinous flooring systems, today announced that it has completed the acquisition of Chips Unlimited, the second largest producer of decorative flake products. Terms of the transaction were not disclosed.
Headquartered in Tempe, AZ, Chips Unlimited is recognized for its high-quality decorative chip/flake products and leading design innovation. The transaction brings together two highly complementary businesses and meaningfully enhances Torginol's ability to serve customers with broader product availability, rapid lead times and expanded customization options. Chips Unlimited's footprint in high-growth domestic, international and specialty markets add further scale to Torginol's platform while creating opportunities to deepen customer relationships.
Jason LaBouve, Chief Executive Officer of Torg...
|
|
|
03.12.25 - 14:06
|
Excelsior Sciences Raises $95 Million to Transform Small Molecule Discovery and Manufacturing with Novel Chemistry that Machines Can Do (Business Wire)
|
|
|
Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical development while supporting pharma reshoring.
NEW YORK--(BUSINESS WIRE)--Excelsior Sciences, a company developing a new form of chemistry that machines can do and AI can use to enable closed-loop drug discovery, today announced it has raised $95 million to accelerate its mission to reinvent the process of discovering and manufacturing small molecules.
The financing includes a $70 million Series A, co-led by Deerfield Management, Khosla Ventures, and Sofinnova Partners, as well as a $25 million grant from New York's Empire State Development. Other participants include Cornucopian Capital, Eli Lilly and Company, Illinois Ventures, and the leading academic institution, MIT.
A Novel Approach for Small Molecule Science
Small molecules, the class of chemical matter primarily built from carbon-carbon bonds, perform countless essential functions in our lives: ...
|
|
|
03.12.25 - 14:06
|
Redfin Reports 15% of Home Purchases Fell Through in October, Up Slightly From a Year Earlier (Business Wire)
|
|
|
Homebuyers are getting cold feet due to high housing costs and economic uncertainty. Many are convinced they'll be able to find a home they like better because there are so many listings on the market.
Homebuyers are most likely to walk away in Texas and Florida, and least likely in Nassau County, NY and the Bay Area.
SEATTLE--(BUSINESS WIRE)--Roughly 53,000 U.S. home-purchase agreements were canceled in October, equal to 15.1% of homes that went under contract that month, according to a new report from Redfin, the real estate brokerage powered by Rocket. That's up from 14.3% a year earlier.
This is based on a Redfin analysis of MLS pending-sales data. The data is seasonal, which is why this October is compared to past Octobers.
Home-purchase cancellations remain elevated for several reasons. High housing costs and economic uncertainty are giving some buyers cold feet. It's also a buyer's market, with home sellers significantly outnumbering homebuyers. This means buyers in most areas have room to nego...
|
|
|
03.12.25 - 14:06
|
Pine Secures $25 Million in Series A Funding to Free Consumers of Digital Chores, Saving Time and Money, and Eliminating Frustration (Business Wire)
|
|
|
PALO ALTO, Calif.--(BUSINESS WIRE)--Pine, the trusted AI agent for consumers' digital chores that delivers results, today announced the close of a $25 million Series A funding round. Investors included Fortwest Capital. This financing positions Pine to advance its “ask-and-it's-done” AI, an autonomous digital agent that makes calls, handles emails and operates software to complete real-world tasks, restoring people's time, money and sanity.
“AI chatbots just answer questions, but Pine actually gets things done,” said Pine CEO Stanley Wei. “Our revolutionary approach gives consumers back hours of their lives with AI they can trust, and our Series A provides new support to scale Pine, the solution consumers have been waiting for.”
Pine's innovative platform alleviates frustration for consumers, who are often worn down by long hold times, endless transfers and unhelpful agents, eventually leading people to give up on fighting for what's rightfully theirs. With Pine, consumers can get the res...
|
|
|
03.12.25 - 14:06
|
KinderCare Learning Companies Announces Return of Tom Wyatt as CEO (Business Wire)
|
|
|
Veteran CEO and current Board Chairman assumes leadership role
LAKE OSWEGO, Ore.--(BUSINESS WIRE)--KinderCare Learning Companies (NYSE: KLC) (“KinderCare”), a leading provider of high-quality early childhood education, today announced that Tom Wyatt is returning as Chief Executive Officer, effective December 2, 2025. Wyatt spent over a decade as CEO of KinderCare and will remain as Chairman of the Board. He is succeeding former CEO Paul Thompson, who stepped down as a board member, and will remain employed by KinderCare through December 31, 2025 to facilitate a smooth transition.
“We are grateful for Paul's many contributions throughout his long career here at KinderCare and wish him all the best,” said Jean Desravines, Lead Independent Director on KinderCare's Board of Directors. "We are excited to welcome Tom back to the CEO role. Tom's transformative leadership and unique experience with KinderCare make him the right person to lead the Company through this next important phase of growth...
|
|
|
03.12.25 - 14:06
|
TRIANA Biomedicines Announces Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline (Business Wire)
|
|
|
Financing co-led by new investors, Ascenta Capital and Bessemer Venture Partners
Additional new investors included YK Bioventures, Regeneron Ventures, Invus, and Finchley Healthcare Ventures, along with continued support from existing investors
Funding will support the advancement of lead asset, TRI-611, an ALK-targeted molecular glue degrader, to clinical proof of concept, for ALK+ NSCLC patients and accelerate maturation of multiple pipeline programs
LEXINGTON, Mass.--(BUSINESS WIRE)--TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused on advancing a target-first and proximity-first molecular glue discovery platform to address difficult to drug disease targets, today announced the successful closing of its oversubscribed $120 million Series B financing round.
The Series B financing was co-led by Ascenta Capital and Bessemer Venture Partners. New investors included YK Bioventures, Regeneron Ventures, Invus, and Finchley Healthcare Ventures. TRIANA received continued support fr...
|
|
|
03.12.25 - 14:06
|
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing (Business Wire)
|
|
|
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President: Toshiaki Nagasato) today announced a strategic equity investment in Lyric Bio, Inc. (Head Office: San Carlos, USA, founded by Chief Executive Officer: Kayj Shannon and Chief Scientific Officer Melanie Matheu).
Through this investment, Meiji Seika Pharma seeks to accelerate the early-stage development of Lyric Bio's innovative platform for producing human immunoglobulin (IVIg), explore donation-independent manufacturing methods, and lay the groundwork for a more resilient, high-quality supply of plasma-derived therapeutics to meet increasing global demand.
Lyric Bio is developing a next-generation biomanufacturing platform for IVIg production. The company's approach uses tissue-mimicking bioreactors built on a proprietary laser-printed cellular substrate that enables ultra high-density cell growth and has the potential to deliver more than 1,000 IVIg doses from a single donor.
This investment will accelerate Lyr...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
